Justin Patrick Sells 206 Shares of Itron (NASDAQ:ITRI) Stock

Itron, Inc. (NASDAQ:ITRI) SVP Justin Patrick sold 206 shares of the business’s stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $79.60, for a total transaction of $16,397.60. Following the sale, the senior vice president owned 32,925 shares of the company’s stock, valued at approximately $2,620,830. This represents a 0.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Price Performance

ITRI opened at $83.02 on Friday. The company has a quick ratio of 2.24, a current ratio of 2.66 and a debt-to-equity ratio of 0.97. Itron, Inc. has a 52-week low of $77.77 and a 52-week high of $142.00. The company has a 50 day moving average of $88.45 and a two-hundred day moving average of $94.52. The company has a market cap of $3.68 billion, a P/E ratio of 13.24, a P/E/G ratio of 0.72 and a beta of 1.35.

Itron (NASDAQ:ITRI) last released its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.23. Itron had a net margin of 12.31% and a return on equity of 19.54%. The company had revenue of $586.98 million during the quarter, compared to the consensus estimate of $572.04 million. During the same period in the previous year, the firm earned $1.52 earnings per share. Itron’s revenue for the quarter was down 3.3% on a year-over-year basis. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. On average, analysts expect that Itron, Inc. will post 6.01 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have issued reports on ITRI. Oppenheimer boosted their price objective on shares of Itron from $133.00 to $135.00 and gave the stock an “outperform” rating in a research note on Thursday, April 16th. Zacks Research raised shares of Itron from a “strong sell” rating to a “hold” rating in a research note on Thursday, February 26th. Roth Mkm reiterated a “buy” rating and issued a $136.00 price objective on shares of Itron in a report on Wednesday, April 29th. JPMorgan Chase & Co. lowered their target price on Itron from $133.00 to $113.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Itron in a research report on Friday, May 8th. Eight equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $131.22.

Institutional Trading of Itron

A number of hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. increased its stake in shares of Itron by 2.3% in the third quarter. Vanguard Group Inc. now owns 5,875,153 shares of the scientific and technical instruments company’s stock worth $731,809,000 after buying an additional 132,329 shares during the last quarter. Impax Asset Management Group plc boosted its stake in Itron by 127.3% during the 3rd quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock valued at $197,153,000 after acquiring an additional 890,040 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Itron by 20.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,536,081 shares of the scientific and technical instruments company’s stock worth $137,659,000 after acquiring an additional 265,039 shares in the last quarter. Geode Capital Management LLC grew its holdings in Itron by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company’s stock worth $106,340,000 after acquiring an additional 6,598 shares in the last quarter. Finally, Handelsbanken Fonder AB increased its position in shares of Itron by 6.0% in the 3rd quarter. Handelsbanken Fonder AB now owns 999,882 shares of the scientific and technical instruments company’s stock worth $124,545,000 after purchasing an additional 56,318 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Key Headlines Impacting Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Stephens reiterated an Overweight rating on Itron and kept a $130 price target, signaling substantial upside versus recent trading levels.
• Neutral Sentiment: Several Itron executives sold small amounts of stock, but the filings say the shares were sold mainly to cover tax withholding tied to equity award vesting, which makes the insider activity look routine rather than a major red flag.
• Negative Sentiment: Zacks Research cut multiple future earnings estimates for Itron, including a sharp reduction to Q4 2027 EPS and a lower FY2027 outlook, suggesting softer profit growth ahead.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.